ATRN

ATRN (Attractin) is a multidomain glycoprotein produced as functionally distinct secreted and membrane-bound isoforms whose roles span immune cell interaction, CNS myelination, and receptor regulation (PMID:10811918, PMID:11444801). The two isoforms arise by alternative splicing: a soluble form terminating at a LINE-1 retrotransposon-derived exon, and a membrane form that splices over this exon to add transmembrane and cytoplasmic domains (PMID:10811918); activated leukocytes first display the membrane isoform on the surface and then release the soluble form (PMID:10811918). The secreted protein, a 175 kDa serum glycoprotein with DPPIV enzymatic activity, is released by activated T lymphocytes and drives monocyte spreading, T cell clustering, and co-stimulation of T-cell antigen responses (PMID:9736737, PMID:8596018). The membrane isoform acts as a transmembrane adapter, recruiting the E3 ubiquitin ligase MGRN1 through MGRN1's RING domain to the melanocortin receptors MC1R and MC4R, enabling their ubiquitination and degradation [PMID:bio_10.1101_2025.03.25.645338]. Loss-of-function mutations establish ATRN as essential for CNS integrity: mouse mutants develop spongiform vacuolization across the brain and spinal cord (PMID:11444801), and a homozygous human splice-site mutation causes hypomyelinating leukodystrophy (PMID:28493104). In zebrafish embryos, Atrn binds the demethylase Alkbh4 and is required for actomyosin contractile ring formation during epiboly (PMID:28924386), and transmembrane ATRN additionally serves as a shared cell-surface entry receptor for a modular family of bacterial exotoxins [PMID:bio_10.1101_2025.10.08.681221].

1. 1996 Medium

   Established that the serum 175-kDa DPPT-L species is distinct from CD26/DPPIV yet retains DPPIV enzymatic activity and co-stimulates T-cell responses, defining an immune-modulatory secreted protein.

   Evidence Biochemical characterization, enzymatic assay, and T-cell co-stimulation assay with recall antigen

   PMID:8596018

   Open questions at the time

   • Catalytic mechanism and physiological substrates of the DPPIV activity not defined
   • Receptor/ligand mediating co-stimulation not identified
2. 1998 Medium

   Cloning identified ATRN as a T-cell-secreted glycoprotein that mediates monocyte spreading and T cell clustering, and sequence analysis defined its multidomain architecture (protease serine, EGF, CUB, C-type lectin, gamma-chain-like motifs).

   Evidence Protein/cDNA cloning with cell adhesion/clustering functional assays and sequence-based domain mapping

   PMID:9736737

   Open questions at the time

   • Binding partners mediating clustering not identified
   • Functional contributions of individual domains untested
3. 2000 High

   Resolved how a single gene yields opposing forms by showing alternative splicing—gated by a LINE-1-derived exon—produces secreted versus membrane isoforms, with surface membrane ATRN preceding soluble release upon leukocyte activation.

   Evidence Genomic exon mapping, RT-PCR isoform quantification, and secretion assay on PHA-activated leukocytes

   PMID:10811918

   Open questions at the time

   • Mechanism cleaving/releasing the soluble form from membrane ATRN not defined
   • Regulation of the splicing switch unknown
4. 2001 High

   Demonstrated that ATRN is required for CNS integrity independent of its coat-color role, since loss-of-function mouse alleles produce spongiform neurodegeneration.

   Evidence Allelism tests, Northern/Southern blot, and histopathology of three independent mouse Atrn mutant alleles

   PMID:11444801

   Open questions at the time

   • Molecular pathway linking ATRN loss to vacuolization not established
   • Cell type responsible not pinpointed
5. 2017 Medium

   Confirmed in humans that ATRN loss-of-function causes hypomyelinating leukodystrophy, translating the mouse CNS phenotype to human disease.

   Evidence Whole exome sequencing and patient cDNA analysis of an aberrant splice product (c.3068+5G>A)

   PMID:28493104

   Open questions at the time

   • Single family limits genotype-phenotype generalization
   • Mechanistic role of ATRN in myelin formation not defined
6. 2017 Medium

   Identified a morphogenetic role by showing Atrn binds the demethylase Alkbh4 and is required for actomyosin contractile ring formation during embryonic epiboly.

   Evidence Zebrafish CRISPR maternal mutants and morpholino knockdown, actin/NMII immunofluorescence, and yeast two-hybrid interaction with preference for active Alkbh4

   PMID:28924386

   Open questions at the time

   • Whether the Atrn-Alkbh4 axis operates in mammals or CNS unknown
   • Direct biochemical demethylation mechanism not reconstituted
7. 2025 Medium

   Defined a mechanistic role for membrane ATRN as an adapter that recruits the E3 ligase MGRN1 to drive ubiquitination and degradation of melanocortin receptors MC1R and MC4R, controlling receptor surface levels.

   Evidence Co-IP of ATRN-MGRN1 (RING domain), receptor ubiquitination/degradation assays, and surface/ciliary receptor imaging (preprint)

   PMID:bio_10.1101_2025.03.25.645338

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • Whether this pathway underlies the CNS or coat-color phenotypes not tested
8. 2025 Medium

   Established transmembrane ATRN as a shared cell-surface entry receptor for a modular family of bacterial exotoxins with diverse effector domains.

   Evidence Insect CRISPR screen and functional toxin entry assays across multiple toxins (preprint)

   PMID:bio_10.1101_2025.10.08.681221

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • ATRN domain mediating toxin binding not mapped
   • Relevance to mammalian/human ATRN not confirmed

• How ATRN's distinct activities—immune adhesion, MGRN1-mediated receptor degradation, CNS myelination, and actomyosin regulation—are mechanistically connected through its domain architecture remains unresolved.
• No unifying molecular mechanism links the immune, neural, and receptor-regulation roles
• Functional roles of individual ATRN domains untested
• Mechanism by which ATRN loss causes hypomyelination undefined